Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy

Vascular Health and Risk Management

Volumn 4, Issue 2, 2008, Pages 463-469

  Kozdag, Guliz ^a,b   Ciftci, Ercument ^a   Ural, Dilek ^a   Sahin, Tayfun ^a   Selekler, Macit ^a   Agacdiken, Aysen ^a   Demirci, Ali ^a   Komsuoglu, Sezer ^a   Komsuoglu, Baki ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Age; Functional status; Ischemic dilated cardiomyopathy; Nonischemic dilated cardiomyopathy; Restrictive diastolic filling; Silent cerebral infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CHEMISTRY; BRAIN INFARCTION; CARDIOVASCULAR RISK; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL STATUS; HEART FAILURE; HUMAN; INCIDENCE; ISCHEMIC CONGESTIVE CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NON ISCHEMIC CONGESTIVE CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; RISK ASSESSMENT; SILENT CEREBRAL INFARCTION; SYSTOLE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AGED; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ODDS RATIO; PREVALENCE; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 44049107475     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bryan RN, Cai J, Burke G, et al. 1999. Prevalence and anatomic characteristics of infarct-like lesions on MR images of middle-aged adults: the atherosclerosis risk in communities study. AJNR Am J Neuroradiol, 20:1273-80.
2. Büsing KA, Schulte-Sasse C, Flüchter S, et al. 2005. Cerebral infarction: incidence and risk factors after diagnostic and interventional cardiac catheterization - prospective evaluation at diffusion-weighted MR imaging. Radiology, 235:177-83.
3. Cleland JG. 1997. Anticoagulant and antiplatelet therapy in heart failure. Curr Opin Cardiol, 12:276-87.
4. Douglas LM. 2004. Heart Failure. In: Bozkurt B, Mann DL eds. Heart Failure as a Consequence of Dilated Cardiomyopathy. Philedelphia; Elsevier, pp. 363-89.
5. Dries DL, Rosenberg YD, Waclawiw MA, et al. 1997. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol, 29:1074-80.
6. Freudenberger RS, Massie BM. 2005. Silent cerebral infarction in heart failure: vascular or thromboembolic? J Card Fail, 11:485-9.
7. Friday G, Sutter F, Curtin A, et al. 2005. Brain magnetic resonance imaging abnormalities following off-pump cardiac surgery. Heart Surg Forum, 8:105-9.
8. Hoshide S, Kario K, Mitsuhashi T, et al. 2001. Different patterns of silent cerebral infarct in patients with coronary artery disease or hypertension. AHJ, 14:509-15.
9. Howard G, Wagenknecht LE, Cai J, et al. 1998. Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke, 29:913-17.
10. Kase CS, Wolf PA, Chodosh EN, et al. 1989. Prevalence of silent stroke in patients presenting with initial stroke: the Framingham study. Stroke, 20:850-2.
11. Kobayashi S, Okada K, Koide H, et al. 1997. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke, 28:1932-9.
12. Koniaris LS, Goldhaber SZ. 1998. Anticoagulation in dilated cardiomyopathy. J Am Coll Cardiol, 3:745-8.
13. Kotani K, Osaki Y, Sakane N, et al. 2004. Risk factors for silent cerebral infarction in the elderly. Arch Med Res, 35:522-4.
14. Kozdag G, Ciftci E, Vural A, et al. 2006. Silent cerebral infarction in patients with dilated cardiomyopathy:echocardiographic correlates. Int J Cardiol, 107:376-81.
15. Liebetrau M, Steen B, Hamann GF, et al. 2004. Silent and symptomatic infarcts on cranial computerized tomography in relation to dementia and mortality: a population-based study in 85-year-old subjects. Stroke, 35:1816-20.
16. Loh E, Sutton MS, Wun CC, et al. 1997. Ventricular dysfunction and the risk of stroke after myocardial infarction. Engl J Med, 336:251-7.
17. Longstreth WT Jr, Dulberg C, Manolio TA, et al. 2002. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke, 33:2376-82.
18. Maeshima S, Moriwaki H, Ozaki F, et al. 2002. Silent cerebral infarction and cognitive function in middle-aged neurologically healthy subjects. Acta Neurol Scand, 105:179-84.
19. [NINDS] National Institute of Neurological Disorders and Stroke. 1990. Classification of cerebrovascular diseases III. Stroke, 21:637-76.
20. Pfeffer MA, Braunwald E, Moye LA, et al. 1992. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlarge-ment trial. The SAVE Investigators. N Engl J Med, 327:669-77.
21. Price TR, Manolio TA, Kronmal RA, et al. 1997. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The cardiovascular health study. CHS Collaborative Research Group. Stroke, 28:1158-64.
22. Reicher-Reiss H, Jonas M, Tanne D, et al. 1998. Prognostic significance of cerebrovascular disease in 11,526 chronic coronary artery disease patients. Bezafibrate Infarction Prevention (BIP) Study Group. Am J Cardiol, 82:1532-35.
23. [WHO] World Health Organization. 1996. Report of the 1995 World health Organization. International society and federation of cardiology. Task-force on the definition and classification of cardiomyopathy. Circulation, 93:841-2.
24. Ricci S, Celani MG, La Rosa F, et al. 1993. Silent brain infarctions in patients with first-ever stroke. A community-based study in Umbria, Italy. Stroke, 24:647-51.
25. Sahn DJ, DeMaria A, Kisslo J, et al. The committee on M-mode standardization of the American society of echocardiography. 1978. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation, 58:1072-83.
26. Sandercock PA, Warlow CP, Jones LN, et al. 1989. Predisposing factors for cerebral infarction: the Oxfordshire community stroke project. BMJ, 298:75-80.
27. Schmidt R, Fazekas F, Offenbacher H, et al. 1991. Brain magnetic resonance imaging and neuropsychologic evaluation of patients with idiopathic dilated cardiomyopathy. Stroke, 22:195-9.
28. Segal AZ, Abernethy WB, Palacios IF, et al. 2001. Stroke as a complication ofcardiac catheterization: risk factors and clinical features. Neurology, 56:975-7.
29. Siachos T, Vanbakel A, Feldman DS, et al. 2005. Silent strokes in patients with heart failure. J Card Fail, 11:485-90.
30. Vanoverschelde JL, Raphael DA, Robert AR, et al. 1990. Left ventricular filling in dilated cardiomyopathy: relation to functional class and hemodynamics. J Am Coll Cardiol, 15:1288-95.
31. Vermeer SE, Koudstaal PJ, Oudkerk M, et al. 2002. Prevalence and risk factors of silent brain infarcts in the population based Rotterdam scan study. Stroke, 33:21-5.
32. Yamashita H, Fujikawa T, Yanai I, et al. 2001. Clinical features and treatment response of patients with major depression and silent cerebral infarction. Neuropsychobiology, 44:176-82.